вторник, 4 септември 2012 г.
Opinion: Why thalidomide apology is not enough
So, after a mere half-century, German pharmaceutical firm Gruenenthal has decided to apologize for the devastating effects its drug, thalidomide, had on thousands of babies and their families around the world, myself included. Is this a reason to celebrate? Is it even a reason for cautious optimism, or is it simply a piece of news management designed to salvage what is left of its corporate reputation?
Абонамент за:
Коментари за публикацията (Atom)
Няма коментари:
Публикуване на коментар